Olcrome-AH Tablet
Marketer
Med Express
Salt Composition
Olmesartan Medoxomil (20mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg)
Overview Olcrome-AH Tablet
Hypersive-Duo tablets combine medications to manage hypertension when monotherapy proves insufficient. This dual-action formula lowers elevated blood pressure, significantly decreasing the risk of stroke and myocardial infarction. Hypersive-Duo may be administered with or without food; dosage is individualized based on your response and health status. Maintain consistent daily timing. Continuous use, as directed by your physician, is crucial. The diuretic component increases urination; therefore, avoid consumption within four hours of bedtime. Regular intake, even during asymptomatic periods, maximizes therapeutic efficacy. Discontinuing treatment elevates the risk of cardiovascular events. Common side effects include pedal edema, cephalalgia, vertigo, fatigue, and altered taste perception. Report persistent, worsening, or intolerable side effects to your doctor immediately. Ample fluid intake helps mitigate potential dehydration symptoms such as myalgia, xerostomia, and polydipsia. Prior to commencing treatment, inform your physician of any renal or hepatic impairment, pregnancy, lactation, or concurrent medications, particularly those for hypertension or cardiac conditions. Regular monitoring of blood pressure, renal function, electrolyte balance, and glycemic levels ensures optimal therapeutic response.
Primary Ingredients of Olcrome-AH Tablet
No information provided. Please provide the text you wish to be rephrased.
Uses of Olcrome-AH Tablet
Elevated blood pressure
Major Benefits of Olcrome-AH Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Olcrome-AH Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Olcrome-AH Tablet:
- Headache
- Dizziness
- Nausea
- Upper respiratory tract infection
- Fatigue
- Urinary tract infection
- Diarrhea
- Joint swelling
- Peripheral edema
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Muscle spasm
- Hypotension (low blood pressure)
- Increased creatinine level in blood
- Increased blood urea
- Increased uric acid level in blood
How to use Olcrome-AH Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Olcrome-AH Tablets can be taken with or without food, although consistent timing is recommended.
How Olcrome-AH Tablet works:
The single tablet, Olcrome-AH, integrates olmesartan medoxomil, amlodipine, and hydrochlorothiazide. Olmesartan medoxomil, an angiotensin II receptor antagonist, and amlodipine, a calcium channel blocker, cooperatively dilate blood vessels, resulting in reduced blood pressure. Hydrochlorothiazide, a diuretic, facilitates the excretion of excess fluid and electrolytes via urination, contributing to vasodilation and enhanced circulation over time.
SAFETY ADVICE
AlcoholUNSAFE
Combining Olcrome-AH Tablet with alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Use of Olcrome-AH Tablets is contraindicated during pregnancy due to established risks to the fetus. In exceptional circumstances involving life-threatening conditions, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Olcrome-AH tablets while breastfeeding is likely inadvisable. Preliminary human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Driving may be impaired by Olcrome-AH Tablet side effects. These side effects can include dizziness, headache, nausea, or fatigue, potentially impacting concentration and driving ability.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Olcrome-AH Tablets, as dose modification may be necessary. Consult a physician before taking Olcrome-AH Tablets if you have severe kidney disease; its use is generally inadvisable in such cases.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Olcrome-AH Tablets. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Olcrome-AH Tablet :
Should you forget to take your Olcrome-AH Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Olcrome-AH Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Heart |


